• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

IQVIA Holdings (IQV)

Sell: $102.17|Buy: $208.84|Change: 3.32 (2.21%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Address

83 Wooster Heights Road
Danbury
CT
USA
06810

Telephone

+1 203 4484600

Website

https://www.iqvia.com

Sector 

Healthcare

Forecast key dates

NameKey Date
IQVIA Holdings Inc Annual General Meeting for 20262026-04-24T09:00:00
IQVIA Holdings Inc Annual Report for 20252026-02-13T00:00:00
IQVIA Holdings Inc Fourth Quarter Earnings Conference Call for 20252026-02-06T09:00:00
IQVIA Holdings Inc Fourth Quarter Earnings Results for 20252026-02-06T00:00:00
IQVIA Holdings Inc Third Quarter Earnings Conference Call for 20252025-10-31T09:00:00
IQVIA Holdings Inc Third Quarter Earnings Results for 20252025-10-31T00:00:00
IQVIA Holdings Inc Second Quarter Earnings Conference Call for 20252025-07-22T09:00:00
IQVIA Holdings Inc Second Quarter Earnings Results for 20252025-07-22T00:00:00
IQVIA Holdings Inc First Quarter Earnings Conference Call for 20252025-05-06T09:00:00
IQVIA Holdings Inc First Quarter Earnings Result for 20252025-05-06T00:00:00
IQVIA Holdings Inc Annual General Meeting for 20252025-04-24T09:00:00

Previous key dates

NameKey Date
IQVIA Holdings Inc Annual General Meeting for 20252025-04-24T09:00:00
TD Cowen Annual Health Care Conference2025-03-04T11:10:00
IQVIA Holdings Inc Annual Report for 20242025-02-13T00:00:00
IQVIA Holdings Inc Fourth Quarter Earnings Conference Call for 20242025-02-06T09:00:00
IQVIA Holdings Inc Fourth Quarter Earnings Result for 20242025-02-06T00:00:00
IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference2024-11-13T13:15:00
IQVIA Holdings Inc Third Quarter Earnings Conference Call for 20242024-10-31T09:00:00
IQVIA Holdings Inc Third Quarter Earnings Result for 20242024-10-31T00:00:00
QVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference2024-09-04T10:00:00
IQVIA Holdings Inc Second Quarter Earnings Conference Call for 20242024-07-22T09:00:00
IQVIA Holdings Inc Second Quarter Earnings Result for 20242024-07-22T00:00:00
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Confere2024-05-14T12:20:00
IQVIA Holdings Inc First Quarter Earnings Conference Call for 20242024-05-02T09:00:00
IQVIA Holdings Inc First Quarter Earnings Result for 20242024-05-02T00:00:00
IQVIA Holdings Inc Annual General Meeting for 20242024-04-16T09:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.